- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 0.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.14 | - |
NAV | ₹16.96 | - |
Fund Started | 14 Sep 2023 | - |
Fund Size | ₹1459.59 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 30 days. | - |
Risk
Very High
-
Rating
0.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.14
-
NAV
₹16.96
-
Fund Started
14 Sep 2023
-
Fund Size
₹1459.59 Cr
-
Exit Load
Exit load of 1%, if redeemed within 30 days.
-
Returns
1 Year | 49.44% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
49.44%
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 98.21% | - |
Cash | 1.79% | - |
Equity
98.21%
-
Cash
1.79%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.48% |
Divi's Laboratories Ltd. | 7.85% |
Cipla Ltd. | 7.75% |
Lupin Ltd. | 5.80% |
Gland Pharma Ltd. | 3.99% |
Ipca Laboratories Ltd. | 3.75% |
Aster DM Healthcare Ltd. | 3.57% |
Vijaya Diagnostic Centre Ltd. | 3.54% |
Eris Lifesciences Ltd. | 3.38% |
Glenmark Pharmaceuticals Ltd. | 3.37% |
-
Fund Manager
Name | Dhruv Muchhal | - |
Start Date | 14 Sep 2023 | - |
Name
Dhruv Muchhal
-
Start Date
14 Sep 2023
-
About Fund
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. | - |
Launch Date | 14 Sep 2023 | - |
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
-
Launch Date
14 Sep 2023
-
